Optimal Management Of Chronic Wounds In Paediatric Junctional Epidermolysis Bullosa Patients

References

• Pfendner EG, Lucky AW. Junctional epidermolysis bullosa. In: Adam MP, Ardinger HH, Pagon RA, et al, editors. GeneReviews^®. Seattle: University of Washington, Seattle; 1993-2019; 2008 February 22 [Updated 2018 December 20].
   Google Scholar
• Fine J. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry. JAMA Dermatol. 2016;152(11):1231–1238. doi:10.1001/jamadermatol.2016.2473
   PubMed Web of Science ®Google Scholar
• Yuen WY, Duipmans JC, Molenbuur B, Herpertz I, Mandema JM, Jonkman MF. Long‐term follow‐up of patients with Herlitz‐type junctional epidermolysis bullosa. Br J Dermatol. 2012;167(2):374–382. doi:10.1111/j.1365-2133.2012.10997.x
   Web of Science ®Google Scholar
• Laimer M, Lanschuetzer CM, Diem A, Bauer JW. Herlitz junctional epidermolysis bullosa. Dermatol Clin. 2010;28(1):55–60. doi:10.1016/j.det.2009.10.006
   Web of Science ®Google Scholar
• Cohn HI, Murrell DF. Laryngo-onycho-cutaneous syndrome. Dermatol Clin. 2010;28(1):89–92. doi:10.1016/j.det.2009.10.010
   Web of Science ®Google Scholar
• Goldschneider KR, Good J, Harrop E, et al. Pain care for patients with epidermolysis bullosa: best care practice guidelines. BMC Med. 2014;12:178. doi:10.1186/s12916-014-00178-2
   Web of Science ®Google Scholar
• Arbuckle HA. Bathing for individuals with epidermolysis bullosa. Dermatol Clin. 2010;28(2):265–268. doi:10.1016/j.det.2010.01.003
   Web of Science ®Google Scholar
• Denyer J, Pillay E, Clapham J. Best practice guidelines for skin and wound care in epidermolysis bullosa. An International Consensus. Vienna: Wound International; 2017.
   Google Scholar
• Huang T, Abrams M, Tlougan B, Rademaker A, Paller S. Treatment of staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123(5):e808–e814. doi:10.1542/peds.2008-2217
   PubMed Web of Science ®Google Scholar
• Junctional epidermolysis bullosa (EB) generalised intermediate type; 2017 February. Available from https://www.gosh.nhs.uk/medical-information/search-medical-conditions/junctional-epidermolysis-bullosa-eb-generalised-intermediate-type. Accessed January 22, 2019.
   Google Scholar
• Material safety data sheet proshield Plus; 2014 November 24. Available from: http://www.hrhealthcare.co.uk/product/proshield-plus/. Accessed January 21, 2019.
   Google Scholar
• Flynn D, Williams S. Barrier Creams for skin breakdown. Nurs Residential Care. 2011;13:553–558. doi:10.12968/nrec.2011.13.11.553
   Google Scholar
• Reimer A, Laszig R, Pfeiffer J, et al. Successful multidisciplinary treatment of chronic facial wounds in junctional epidermolysis bullosa. Acta Derm Venereol. 2018;98(7):711–712. doi:10.2340/00015555-2934
   Web of Science ®Google Scholar
• King A, Stellar JJ, Blevins A, Shah KN. Dressings and products in pediatric wound care. Adv Wound Care (New Rochelle). 2014;3(4):324–334. doi:10.1089/wound.2013.0477
   Google Scholar
• Stevens J. Access to wound dressings for patients living with epidermolysis bullosa — an Australian perspective. Int Wound J. 2014;11(5):505. doi:10.1111/j.1742-481X.2012.01116.x
   Web of Science ®Google Scholar
• Plevey K. Management of neonates with dystrophic and missing nails in junctional epidermolysis bullosa generalised severe; 2018. Available from: http://program.m-anage.com/ewma2018/en-GB/ProgramSearch/DownloadAbstractOfPresentation/344124. Accessed January 21, 2019.
   Google Scholar
• Schober-Flores C. Epidermolysis bullosa: the challenges of a chronic wound. J Dermatol. 2014;6(4):199–205.
   Google Scholar
• Van der Kooi-Pol MM, Duipmans JC, Jonkman MF, van Dijl JM. Host-pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus. Int J Med Microbiol. 2014;304(2):195–203. doi:10.1016/j.ijmm.2013.11.012
   Web of Science ®Google Scholar
• Danial C, Adeduntan R, Gorell S, et al. Prevalence and characterization of pruritus in epidermolysis bullosa. Pediatr Dermatol. 2015;32(1):53. doi:10.1111/pde.12391
   PubMed Web of Science ®Google Scholar
• Elmariah SB, Lerner EA. Topical therapies for pruritus. Semin Cutan Med Surg. 2011;30(2):118–126. doi:10.1016/j.sder.2011.04.008
   Web of Science ®Google Scholar
• Freitag G, Höppner T. Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Curr Med Res Opin. 1997;13(9):529–537. doi:10.1185/03007999709113326
   PubMed Web of Science ®Google Scholar
• Denyer JE. Wound management for children with epidermolysis bullosa. Dermatol Clin. 2010;28:257–264. doi:10.1016/j.det.2010.01.002
   PubMed Web of Science ®Google Scholar
• Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain. 2009;25(2):170–175. doi:10.1097/AJP.0b013e3181850df6
   PubMed Web of Science ®Google Scholar
• Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part 1–pharmacokinetics. Paediatr Anaesth. 1997;7(1):5–11.
   PubMedGoogle Scholar
• Harrison D, Stevens B, Bueno M, et al. Efficacy of sweet solutions for analgesia in infants between 1 and 12 months of age: a systematic review. Arch Dis Child. 2010;95:406–413. doi:10.1136/adc.2009.174227
   Web of Science ®Google Scholar
• Chiu YK, Prendiville JS, Bennett SM, Montgomery CJ, Oberlander TF. Pain management of junctional epidermolysis bullosa in an 11-year-old boy. Pediatr Dermatol. 1999;16:465–468. doi:10.1046/j.1525-1470.1999.00120.x
   PubMed Web of Science ®Google Scholar
• De Leeuw TG, Mangiarini L, Lundin R, et al. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials. 2019;20:368.
   Web of Science ®Google Scholar
• Kim M, Jain S, Harris AG, Murrell DF. Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosa. Int J Womens Dermatol. 2016;2:56–59. doi:10.1016/j.ijwd.2016.04.001
   PubMedGoogle Scholar
• Pfendner EG, Lucky AW. Epidermolysis bullosa with pyloric atresia. In: Pagon RA, Adam MP, Ardinger H, et al, editors. GeneReviews®. University of Washington, Seattle; 1993-2017; 2008 February 22; [updated 2017 September 7]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1157/.
   Google Scholar
• Denyer J. Reducing pain during the removal of adhesive and adherent products. Br J Nurs. 2011;20(15):S28–S35. doi:10.12968/bjon.2011.20.Sup8.S28
   Google Scholar
• Sheehan F. Epidermolysis bullosa (EB): management of the newborn infant with EB; 2017 June. Available from: https://www.gosh.nhs.uk/health-professionals/clinical-guidelines/epidermolysis-bullosa-eb-management-newborn-infant-eb#Blister-care. Accessed January 23, 2019.
   Google Scholar
• Lincoln V, Cogan J, Hou Y, et al. Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa. Proc Natl Acad Sci. 2018;115(28):E6536–E6545. doi:10.1073/pnas.1803154115
   PubMed Web of Science ®Google Scholar
• Hammersen J, Neuner A, Wild F, Schneider H. Attenuation of severe generalized junctional epidermolysis bullosa by systemic treatment with gentamicin. Dermatology. 2019;235(4):315–322. doi:10.1159/000499906
   PubMed Web of Science ®Google Scholar
• Lim M, Kirchhof MG. Dermatology-related uses of medical cannabis promoted by dispensaries in Canada, Europe, and the United States. J Cutan Med Surg. 2019;23(2):178–184. doi:10.1177/1203475418808761
   Web of Science ®Google Scholar
• Schräder N, Duipmans J, Molenbuur B, Wolff A, Jonkman M. Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases. Br J Dermatol. 2019;180:922–924. doi:10.1111/bjd.17341
   PubMed Web of Science ®Google Scholar
• De Hoop B, Heerdink ER, Hazekamp A. Medicinal cannabis on prescription in the Netherlands: statistics for 2003–2016. Cannabis Cannabinoid Res. 2018;3:54–55. doi:10.1089/can.2017.0059
   Google Scholar
• Hirsch T, Rothoeft T, Teig N, et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature. 2017;551(7680):327–332. doi:10.1038/nature24487
   PubMed Web of Science ®Google Scholar
• Hammersen J, Has C, Naumann-Bartsch N, et al. Genotype, clinical course, and therapeutic decision making in 76 infants with severe generalized junctional epidermolysis bullosa. J Invest Dermatol. 2016;136(11):2150–2157. doi:10.1016/j.jid.2016.06.609
   PubMed Web of Science ®Google Scholar